.jpg?format=webp&width=780)
A breakthrough in breast cancer treatment unveils a crucial timeframe post-localized cancer treatment, offering a window to eradicate disseminated tumor cells (DTCs) and prevent metastasis. Research shows DTCs evade immune responses, but immunotherapies, including T cell-based vaccination, T cell receptor transfer, or CAR T cells, effectively eliminate DTCs, addressing the scarcity of interactions between DTCs and T cells. This discovery paves the way for targeted immunotherapies against MHC-restricted and -unrestricted DTC antigens, providing hope for preventing metastasis in breast cancer patients.
Like
Save
Share